With over 20 years of experience in HEOR & RWE leadership roles, Canter leads the Lumen agency, providing clients with the path to access and improved patient outcomes through innovative solutions, proven evidence-generation methodologies, and value communications.

Underpinned by fit-for-purpose RWD, scientific rigor and a passion for improving patient lives, his team answers the most challenging clinical and commercial questions and meets the highest delivery and compliance standards.

Dr. Gary Schneider is an epidemiologist/biostatistician with 30-years' experience, predominately in the design, analysis and delivery of RWD/RWE studies directly supporting pharmaceutical and medical device organizations. With experience applied to disease epidemiology, HEOR, value & access, and commercialization projects, Gary has a diverse skill set, including both traditional and innovative methodologies to provide data-driven insights into today's ever-changing healthcare delivery landscape.

Dr. Victoria Malek is a Physician and Public Health Consultant with +9 years of experience in the public, private and international health sectors across Emerging and European markets.

She focuses on the use of RWE to optimize product profiles by assessing and improving client’s evidence generation strategy, identifying unmet need, demonstrating and communicating value to increase market access throughout the product lifecycle.

Dr. Koen Degeling is passionate about supporting patient access to healthcare innovations through fit-for-purpose analyses. He has a PhD in Advanced Health Economic Modeling and 8+ years of experience in the design, conduct, and appraisal of health economic and health services studies using various types of evidence, including RWD/RWE. Koen actively contributes to the global HEOR community, for example as Editorial Board member.